Skip to main content
. 2022 Mar 2;2022:8493519. doi: 10.1155/2022/8493519

Figure 3.

Figure 3

Forest plot of studies evaluating the efficacy of neoadjuvant chemotherapy for cT3-4 on (a) overall survival (OS) and (b) pathological complete response (pCR).